Figure 6.

(A) Effect of NLRC5 genotype on the prognosis in the SUCCESS-A study: Kaplan–Meier curves for disease-free survival relative to neutropenic or leukopenic events (AE) and the NLRC5 rs4784751 genotype (0, zero minor alleles; 1 one minor allele; 2, two minor alleles). (B) Effect of NLRC5 leukocyte expression on the pathological complete response (pCR) in a group of triple-negative breast cancer (TNBC) patients: comparison of white blood cell NLRC5 expression between healthy individuals, patients who achieved a pCR after neoadjuvant chemotherapy, and patients who did not achieve a pCR.